Connecticut General Statutes 32-41mm – Peer review of applications for financial assistance. Qualifications and duties of peer reviewers. Rating and scoring guidelines
(a) Prior to the awarding of any financial assistance in response to an application submitted pursuant to § 32-41kk, the Regenerative Medicine Research Advisory Committee, established pursuant to § 32-41ll, shall contract with a third party for the selection of peer reviewers to review such application and make recommendations to said advisory committee with respect to the ethical and scientific merit of such application.
Terms Used In Connecticut General Statutes 32-41mm
- Contract: A legal written agreement that becomes binding when signed.
- Research: means the scientific and engineering analysis, investigation, collection of ideas and inquiry into concepts, processes and techniques, the purpose of which is intended to result in a commercially feasible product, process or technique. See Connecticut General Statutes 32-34
(b) Such peer reviewers shall: (1) Have a demonstrated knowledge and understanding of the ethical and medical implications of regenerative medicine research or related research fields, including, but not limited to, embryology, genetics or cellular biology; (2) have practical research experience in regenerative medicine research or related research fields, including, but not limited to, embryology, genetics or cellular biology; (3) work to advance regenerative medicine research; and (4) become and remain fully cognizant of the National Academies’ Guidelines for Human Embryonic Stem Cell Research, as amended from time to time, and shall utilize said guidelines to evaluate any application pursuant to subsection (a) of this section.
(c) No peer reviewer shall review any application filed by such peer reviewer or by any eligible institution in which such peer reviewer has a financial interest, or with which such peer reviewer engages in any business, employment, transaction or professional activity.
(d) Such peer reviewers may receive compensation from Connecticut Innovations, Incorporated, for reviewing applications submitted pursuant to § 32-41kk. The rate of compensation shall be established by the board of directors of Connecticut Innovations, Incorporated.
(e) The Regenerative Medicine Research Advisory Committee shall establish guidelines for the rating and scoring of such applications. In establishing such guidelines, said advisory committee may consult with a third party contracted for the selection of peer reviewers pursuant to subsection (a) of this section.